SNPS:NASDAQ

Synopsys (SNPS) is trading well below its DCF fair value of $569, offering roughly a 23% upside at the current $437 price. The company posted a staggering 65.5% year‑over‑year revenue surge to $2.41 B and EPS climbed to $3.77, comfortably beating consensus. Fundamentals remain robust with an 82% gross margin, positive free cash flow exceeding $3 B, and a forward PE of 25.6 suggesting earnings acceleration. Technically, the stock sits beneath its 20‑day (433), 50‑day (466) and 200‑day (493) SMAs, the 30‑day volatility is high at ~52%, and beta is 1.37, indicating heightened market sensitivity. However, the MACD histogram is positive and the signal line turned bullish, hinting at a potential near‑term reversal. Support around $404 and resistance near $454 frame the next price action, while volume is on an upward trend.
Given the strong growth narrative, undervaluation relative to peers, and a fresh $250 M accelerated share repurchase that should support the price, the medium‑ to long‑term outlook is favorable. Investors should monitor the upcoming earnings release for guidance on forward EPS, but the combination of high cash generation, strategic AI‑driven EDA offerings, and a solid balance sheet (despite a high debt‑to‑equity ratio) makes SNPS a compelling buy for those willing to tolerate short‑term volatility.